跳至主要内容
临床试验/NCT02499718
NCT02499718Unknown不适用

Non-invasive Positive Pressure Ventilation for the Treatment of Severe Stable Chronic Obstructive Pulmonary Disease

Guangzhou Institute of Respiratory Disease1 个研究点 分布在 1 个国家目标入组 368 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
368
试验地点
1
主要终点
Severe Respiratory Insufficiency (SRI) Questionnaire

研究概览

简要总结

Assessment of the effect and safety of noninvasive positive pressure ventilation for severe stable chronic obstructive pulmonary disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinically stable, hypercapnic GOLD stage IV COPD, aged 18 years or older, baseline arterial carbon dioxide pressure (PaCO2) of 6.7 kPa (50 mmHg) or higher and a pH higher than 7·35, measured after at least 1 h rest in a sitting position.

排除标准

  • thorax or the lung other than COPD
  • No smoking or Cigarette≤10/day
  • obesity with a bodymass index (BMI) ≥40 kg/m²
  • malignant co-morbidities,severe heart failure (New York Heart Association stage IV),unstable angina, and severe arrhythmias.

结局指标

主要结局

Severe Respiratory Insufficiency (SRI) Questionnaire

时间窗: 1 year

次要结局

  • Baseline Dyspnea Index/Transition Dyspnea Index(1 year)
  • Chromic Respiratory Questionnaire(1 year)
  • The frequency of readmission(1 year)
  • Pulmanory function(1 year)
  • 6 Minute-Walking Distance and Borg Score(1 year)
  • Chronic Obstructive Pulmonary Disease (COPD) Assessment Test(1 year)
  • Blood gas analysis(1 year)
  • The frequency of exacerbation(1 year)
  • The frequency of ICU readmission(1 year)
  • survival rate(1 year)

研究者

发起方
Guangzhou Institute of Respiratory Disease
申办方类型
Other
责任方
Principal Investigator
主要研究者

LuQian Zhou

Assistant Professor of Guangzhou Institute of Respiratory Disease

Guangzhou Institute of Respiratory Disease

研究点 (1)

Loading locations...

相似试验